The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer

[1]  Tomonari Matsuda,et al.  Reduced expression of MUTYH with suppressive activity against mutations caused by 8‐hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer , 2011, The Journal of pathology.

[2]  K. Chu,et al.  NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. , 2011, Carcinogenesis.

[3]  Z. Garrett,et al.  NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer. , 2011, The Lancet. Oncology.

[4]  S. Perrotta,et al.  p57Kip2 is a downstream effector of BCR-ABL kinase inhibitors in chronic myelogenous leukemia cells. , 2011, Carcinogenesis.

[5]  Satoki Nakamura,et al.  The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. , 2010, Carcinogenesis.

[6]  Y. Nakabeppu,et al.  Adenine DNA Glycosylase Activity of 14 Human MutY Homolog (MUTYH) Variant Proteins Found in Patients with Colorectal Polyposis and Cancer , 2010, Human mutation.

[7]  Christopher Logothetis,et al.  Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors. , 2010, Cancer treatment reviews.

[8]  H. Sugimura,et al.  Fluorescence in situ hybridization analysis with a tissue microarray: ‘FISH and chips’ analysis of pathology archives , 2010, Pathology international.

[9]  J. Bergh,et al.  Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial , 2010, Journal of Translational Medicine.

[10]  M. Baccarani,et al.  Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a ‘head-to-head comparison’ , 2010, Leukemia & lymphoma.

[11]  H. Kantarjian,et al.  Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase , 2010, Cancer.

[12]  R. Birge,et al.  Crk and CrkL adaptor proteins: networks for physiological and pathological signaling , 2009, Cell Communication and Signaling.

[13]  H. Sugimura,et al.  Copy number estimation algorithms and fluorescence in situ hybridization to describe copy number alterations in human tumors , 2009, Pathology international.

[14]  岩泉 守哉.  Human Sgo1 downregulation leads to chromosomal instability in colorectal cancer , 2009 .

[15]  Sorin V. Sabau,et al.  A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth , 2009, BMC Cancer.

[16]  K. Fukasawa,et al.  Induction of centrosome amplification and chromosome instability in p53‐deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE) , 2008, The Journal of pathology.

[17]  P. Assumpção,et al.  MYC and gastric adenocarcinoma carcinogenesis. , 2008, World journal of gastroenterology.

[18]  Yun-Wei Lin,et al.  Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells. , 2008, Carcinogenesis.

[19]  Satoki Nakamura,et al.  HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells. , 2008, Leukemia research.

[20]  Yusuke Nakamura,et al.  Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer , 2008, Nature Genetics.

[21]  Nayoung Kim,et al.  Gene expression of AGS cells stimulated with released proteins by Helicobacter pylori , 2008, Journal of gastroenterology and hepatology.

[22]  H. Sugimura.  Detection of chromosome changes in pathology archives: an application of microwave-assisted fluorescence in situ hybridization to human carcinogenesis studies. , 2008, Carcinogenesis.

[23]  Motohiro Kato,et al.  Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. , 2007, American journal of human genetics.

[24]  Ji Eun Kim,et al.  Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer. , 2007, Genomics.

[25]  Seishi Ogawa,et al.  Genome-wide copy number analysis on GeneChip platform using copy number analyzer for affymetrix GeneChip 2.0 software. , 2007, Methods in molecular biology.

[26]  Donna Neuberg,et al.  Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. , 2005, Cancer cell.

[27]  E. Tahara.  Genetic pathways of two types of gastric cancer. , 2004, IARC scientific publications.

[28]  Takeshi Nakamura,et al.  Grit, a GTPase-Activating Protein for the Rho Family, Regulates Neurite Extension through Association with the TrkA Receptor and N-Shc and CrkL/Crk Adapter Molecules , 2002, Molecular and Cellular Biology.

[29]  D. Roder,et al.  The epidemiology of gastric cancer , 2002, Gastric Cancer.

[30]  S. Feller.  Crk family adaptors–signalling complex formation and biological roles , 2001, Oncogene.

[31]  S. Feller,et al.  Cell‐penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  J. Yokota,et al.  Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. , 1999, Carcinogenesis.

[33]  R. Salgia,et al.  Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells , 1998, Leukemia.

[34]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.

[35]  N. Heisterkamp,et al.  Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia. , 1994, Blood.

[36]  N. Heisterkamp,et al.  Isolation and chromosomal localization of CRKL, a human crk-like gene. , 1993, Oncogene.